Form 4: Strata Critical Medical Director Sells Shares

Reginald Love, a Director at Strata Critical Medical, Inc., reported the sale of 11,000 shares of Class A common stock on November 19, 2025, at a weighted average price of $4.3122 per share.

Summary

• Reginald Love, a Director of Strata Critical Medical, Inc. (SRTA), reported a transaction involving the company's securities.
• The transaction occurred on November 19, 2025.
• Love disposed of 11,000 shares of Class A common stock, with a par value of $0.0001 per share.
• The shares were sold at a weighted average price of $4.3122 per share, with individual trades executed in multiple trades at prices ranging from $4.31 to $4.32, inclusive.
• Following this transaction, Reginald Love beneficially owns 124,897 shares of Class A common stock directly.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: This is a routine Form 4 filing reporting an insider stock sale. The transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not necessarily a reaction to new information, thus maintaining a neutral sentiment.

Future Outlook

N/A. This filing reports a past insider transaction and does not provide forward-looking statements or guidance regarding the company's future performance.

Industry Context

N/A. This filing is a routine insider transaction report and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: A director's sale of shares, even if routine and pre-planned under a 10b5-1 plan, can sometimes be perceived with minor caution, though the relatively small volume (11,000 shares) mitigates significant concern.

Key Dates

Keywords

Strata Critical Medical, SRTA, Reginald Love, Insider Transaction, Form 4, Stock Sale, Director Transaction, Equity Disposal, 10b5-1 Plan